s.hartmann
TL2 Moderator · Tampere
Contributes reviews on supplier material. Based in Tampere.
Joined 14 April 2025 · last posted 3d
95 posts, newest first. Showing up to 150.
-
Here for the analytics and not much else Replied, post #88 · Lounge › Introductions · 25 Jul 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
What is genuinely unknown about long-term amylin agonism Replied, post #80 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 7 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #51 · Research Methods › Statistics · 21 Jul 2026 · 10 likes On post #47 — agreed on the reasoning, with one qualification. Regression to the mean: if you select people with extreme values (very high or very low), their next…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #49 · Sourcing › Regulatory · 21 Jul 2026 · 30 likes Coming back to post #47, because the follow-up matters more than the original answer. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #98 · Data & Tools › Datasets · 19 Jul 2026 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
Why the cheapest option is often not the cheapest Replied, post #20 · Access › Pricing · 16 Jul 2026 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Athletes in weight-category sports: a different risk calculus Replied, post #28 · Clinical › Special populations · 16 Jul 2026 · 0 likes post #27 answers the question as asked. The question underneath it is different. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #101 · Evidence › Preprints · 9 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #36 · Practice › Reconstitution · 4 Jul 2026 · 26 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #52 · Access › Insurance & coverage · 3 Jul 2026 · 11 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #25 · Nutrition & Training › Protein & intake · 2 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #58 · Evidence › Journal club · 25 Jun 2026 · 1 like On post #54 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #128 · Access › Insurance & coverage · 20 Jun 2026 · 17 likes Coming back to post #126, because the follow-up matters more than the original answer. Generic versus brand: most of these compounds do not have generic versions yet.…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #27 · Research Methods › N-of-1 designs · 12 Jun 2026 · 0 likes post #26 answers the question as asked. The question underneath it is different. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #34 · Compounds › Oral incretins · 9 Jun 2026 · 7 likes Worth separating two things that post #30 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #72 · Practice › Storage & stability · 6 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Injection volume, overload, and peak distortion Replied, post #38 · Analytics › HPLC & UHPLC · 6 Jun 2026 · 8 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Revisiting: The best-written scientific paper you have read Replied, post #7 · Lounge › Off topic · 29 May 2026 · 15 likes This follows post #4 rather than contradicting it. Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan…
-
Reading a home test result without over-claiming Replied, post #34 · Analytics › Home & field testing · 7 May 2026 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Review: an evidence digest and the citation check that delayed it Replied, post #3 · Documentation › Doc review · 18 Apr 2026 · 6 likes post #2 answers the question as asked. The question underneath it is different. Interdependencies: if updating one page requires updating related pages, posting that…
-
Journal club: is percentage weight change the right endpoint? Replied, post #46 · Evidence › Journal club · 7 Apr 2026 · 1 like SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #7 · Evidence › Meta-analyses · 3 Apr 2026 · 20 likes This follows post #4 rather than contradicting it. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #88 · Analytics › Mass spectrometry · 30 Mar 2026 · 8 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #48 · Evidence › Trials · 29 Mar 2026 · 31 likes On post #44 — agreed on the reasoning, with one qualification. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
-
A calculator that gives a right answer to the wrong question Replied, post #10 · Data & Tools › Calculators · 16 Mar 2026 · 23 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Designing a personal experiment that could change your mind — one year on Replied, post #17 · Research Methods › N-of-1 designs · 4 Mar 2026 · 27 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Measurement error in a self-reported exposure Replied, post #92 · Evidence › Study critique · 26 Feb 2026 · 0 likes This follows post #89 rather than contradicting it. When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #66 · Practice › Storage & stability · 14 Feb 2026 · 0 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #18 · Evidence › Study critique · 31 Jan 2026 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #50 · Practice › Dosing & titration · 30 Jan 2026 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Trifluoroacetate content and its consequences Replied, post #10 · Analytics › Impurities & related substances · 23 Jan 2026 · 25 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #20 · Clinical › Bloodwork · 16 Jan 2026 · 7 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
A partial dose because the pen emptied mid-injection Replied, post #60 · Practice › Administration · 9 Jan 2026 · 2 likes Worth separating two things that post #56 runs together. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
-
Revisiting: Absolute versus relative contraindications Replied, post #10 · Safety › Contraindications · 1 Jan 2026 · 18 likes post #9 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Search filters: what is missing Replied, post #10 · Meta › Site feedback · 16 Dec 2025 · 0 likes Picking up post #7: that is the part I would want checked first. Search and findability: if you searched for something and did not find it, report what you searched for…
-
The headache that turns out to be dehydration Replied, post #86 · Nutrition & Training › Hydration & electrolytes · 8 Dec 2025 · 8 likes Picking up post #83: that is the part I would want checked first. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #33 · Sourcing › Independent verification · 5 Dec 2025 · 14 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Second pass at: Programming during a large energy deficit Replied, post #83 · Nutrition & Training › Resistance training · 16 Nov 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
[2026 update] What steady state means for the decision to escalate Replied, post #106 · Practice › Dosing & titration · 16 Nov 2025 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Substitution between formats during a shortage Replied, post #94 · Access › Shortages · 12 Nov 2025 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Gauge and length selection for subcutaneous injection Replied, post #49 · Devices › Syringes & needles · 11 Nov 2025 · 0 likes Sharps disposal: needles and syringes should be disposed in a sharps container (a rigid, puncture-resistant container). Do not put them in regular trash. Many…
-
EMA product information as a primary source Replied, post #44 · Regional › European Union · 8 Nov 2025 · 0 likes Netherlands: CBG-MEB implements framework. GPs are first point of contact. Insurance coverage for weight management is conditional on structured lifestyle programme…
-
[2026 update] Scheduled maintenance and what will be unavailable Replied, post #20 · Meta › Announcements · 5 Nov 2025 · 16 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
A 40-week log with the measurement method stated Replied, post #91 · Outcomes › Progress reports · 29 Oct 2025 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 40-week log with the measurement method stated Replied, post #72 · Outcomes › Progress reports · 26 Oct 2025 · 0 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
Where to report an adverse event officially, by region — a second dataset Replied, post #45 · Safety › Adverse events · 22 Oct 2025 · 0 likes Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant urgent evaluation. Severe dehydration during weight loss is a…
-
Cross-border purchase rules within the EU Replied, post #22 · Regional › European Union · 10 Oct 2025 · 21 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: PIONEER 6 as a safety trial Replied, post #5 · Evidence › Journal club · 5 Oct 2025 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Managing an unplanned gap in supply — what changed since Replied, post #73 · Access › Shortages · 27 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Compounds this community declines to help with, and why Replied, post #8 · Compounds › Other compounds · 24 Sep 2025 · 0 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Thyroid function tests during substantial weight change Replied, post #67 · Clinical › Bloodwork · 19 Sep 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Angle of injection and whether 90 degrees is always right Replied, post #17 · Practice › Administration · 1 Sep 2025 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Comparing the STEP programme populations: who was actually enrolled — the long version Replied, post #5 · Compounds › Semaglutide · 31 Aug 2025 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Regional warehouse stock versus direct despatch Replied, post #11 · Sourcing › Logistics · 29 Aug 2025 · 10 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #99 · Compounds › Secretagogues & GH axis · 25 Aug 2025 · 0 likes Picking up post #96: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Oral semaglutide bioavailability and its variability between people Started this topic · Compounds › Oral incretins · 15 Aug 2025 · 4 likes Posting this under the heading it deserves: Oral semaglutide bioavailability and its variability between people Everything below is what sits behind that. I have seen…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #18 · Practice › Administration · 13 Aug 2025 · 7 likes Coming back to post #16, because the follow-up matters more than the original answer. A site rotation scheme that actually works: abdomen, outer thigh, back of arm,…
-
Washout: how long is long enough, and for what purpose Replied, post #52 · Pharmacology › Pharmacokinetics · 4 Aug 2025 · 1 like SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
A comparison of home results against a laboratory result on the same vial Replied, post #18 · Analytics › Home & field testing · 26 Jul 2025 · 1 like Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
[2026 update] Documentation that materially improves an appeal's chances Replied, post #3 · Access › Insurance & coverage · 10 Jul 2025 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Pages past their review date, listed Replied, post #4 · Meta › Wiki maintenance · 8 Jul 2025 · 30 likes This follows post #3 rather than contradicting it. Outdated external links: if a maintained page links to external sources and those links are broken or pages have…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #25 · Analytics › HPLC & UHPLC · 25 Jun 2025 · 10 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #27 · Clinical › Special populations · 21 Jun 2025 · 29 likes post #26 is right about the mechanism and I think understates the practical bit. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #6 · Analytics › HPLC & UHPLC · 11 Jun 2025 · 0 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Cost per milligram, computed honestly across formats — a second dataset Replied, post #2 · Access › Pricing · 29 May 2025 · 0 likes the opening post answers the question as asked. The question underneath it is different. Compute cost per delivered dose at your dose if you want a number you can act…
-
Why plausible mechanism is not evidence of effect Replied, post #9 · Compounds › Repair & healing peptides · 9 May 2025 · 4 likes Picking up post #6: that is the part I would want checked first. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
-
Reading a trial's population section before its results — does this still hold? Replied, post #53 · Evidence › Trials · 30 Apr 2025 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #95 · Documentation › Doc review · 8 Apr 2025 · 0 likes post #94 is right about the mechanism and I think understates the practical bit. Multilingual versions: if a maintained page should exist in another language,…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #19 · Sourcing › Vendor reports · 4 Apr 2025 · 5 likes post #18 answers the question as asked. The question underneath it is different. Multiple services on one lot: agreement across two independent laboratories is stronger…
-
A promotion I argued against, and why I lost Replied, post #156 · Documentation › Doc review · 1 Apr 2025 · 2 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
-
Units, standards, and other things that quietly hold the world together Replied, post #2 · Lounge › Off topic · 18 Mar 2025 · 7 likes Picking up the opening post: that is the part I would want checked first. Industry and supply chain: post about manufacturing, pharmaceutical economics, or market…
-
Why side effects reset at each escalation and that is not a failure — the long version Replied, post #3 · Practice › Side effects · 11 Mar 2025 · 1 like Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Charge states for a 4 kDa peptide, worked through Replied, post #33 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #16 · Regional › UK & Ireland · 13 Feb 2025 · 31 likes Worth separating two things that post #12 runs together. MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing…
-
Fibre intake when total intake falls, and the constipation link Replied, post #25 · Nutrition & Training › Protein & intake · 6 Feb 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Distinguishing a deletion sequence by mass alone Replied, post #19 · Analytics › Mass spectrometry · 26 Jan 2025 · 30 likes post #18 is right about the mechanism and I think understates the practical bit. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Attributing a new peak: degradation product or excipient? Started this topic · Analytics › Impurities & related substances · 17 Jan 2025 · 0 likes Asking directly, because I could not find a straight answer: Attributing a new peak: degradation product or excipient? Posting the method first, because I know what the…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #12 · Practice › Reconstitution · 15 Jan 2025 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What changed in 2026, by region Replied, post #56 · Access › International · 3 Jan 2025 · 27 likes This follows post #53 rather than contradicting it. Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #22 · Compounds › Oral incretins · 25 Dec 2024 · 7 likes This follows post #19 rather than contradicting it. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a…
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #51 · Evidence › Trials · 22 Dec 2024 · 0 likes I read post #49 twice before replying, because I had assumed the opposite. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #131 · Compounds › Other compounds · 21 Nov 2024 · 22 likes post #130 is right about the mechanism and I think understates the practical bit. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
A promotion I argued against, and why I lost Replied, post #4 · Documentation › Doc review · 12 Nov 2024 · 0 likes Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
-
Converting between mg/mL and units per dose, both directions Replied, post #84 · Practice › Reconstitution · 10 Nov 2024 · 7 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
About the Payments category Replied, post #3 · Sourcing › Payments · 2 Nov 2024 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #5 · Clinical › Special populations · 29 Oct 2024 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
US compounding rules and how they changed Replied, post #44 · Regional › North America · 28 Oct 2024 · 4 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Converting between mg/mL and units per dose, both directions Replied, post #65 · Practice › Reconstitution · 26 Oct 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #8 · Compounds › Other compounds · 25 Oct 2024 · 28 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Turnaround times and what they mean for a decision — one year on Replied, post #6 · Sourcing › Independent verification · 9 Oct 2024 · 1 like VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #3 · Sourcing › Regulatory · 23 Sep 2024 · 16 likes Picking up post #2: that is the part I would want checked first. Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #66 · Compounds › Semaglutide · 22 Sep 2024 · 6 likes Picking up post #63: that is the part I would want checked first. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in…
-
Why a preprint's supplementary material is often the best part Replied, post #5 · Evidence › Preprints · 28 Aug 2024 · 1 like On the opening post — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint].…
-
Tracking a preprint to publication: a worked example — the long version Replied, post #29 · Evidence › Preprints · 22 Aug 2024 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Journal club: FLOW and the renal composite, component by component Replied, post #44 · Evidence › Journal club · 13 Jul 2024 · 25 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…